Latrunculin B: Strategic Disruption of Actin Cytoskeleton...

2026-01-20

Latrunculin B, a cell-permeable actin polymerization inhibitor, is redefining the experimental landscape for cytoskeletal organization studies and cellular actin dynamics research. This article delivers a mechanistic deep-dive, competitive benchmarking, and actionable guidance for translational researchers—bridging the gap between foundational biochemistry and applied biomedical innovation. By integrating recent literature, including pivotal findings on viral entry and cytoskeletal roles, we articulate a visionary roadmap for leveraging Latrunculin B in next-generation disease modeling and therapeutic exploration.